Clintrax’s tenured experience with global budget development, coupled with the depth of local country knowledge allows us to create accurate forecasts and highly detailed country-specific budgets that align logically with payment processes, which promote efficient negotiations that reduce cycle time. Budgets are tailored at the procedure level to the specific therapeutic area and country to ensure global payments are at fair market value to mitigate compliance risks. On-going analysis of negotiated budgets is continued throughout the study, delivering vital feedback to clients with regards to their budgetary position.
In order to accurately assess line-item fair market value, Clintrax utilizes an industry-leading benchmarking tool with global positioning from negotiated grant information in over 90 countries. Clintrax accesses fair market value data from 4800 procedures and 15 million industry cost data points that are updated quarterly and reflect the most recent 24 month period, solidifying the validity of our budget development and projected negotiations.